Form D · Biotechnology

Kona Medical, Inc.

Bellevue, WA · CIK 0001490581

Offering snapshot reported Sep 2, 2015 · SEC filing

Reported sold
$10M
Offering amount: $22.4M
Investors reported
17
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Aug 20, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 2, 2015Initial$10,000,300No comparison17SEC filing
Jun 7, 2012Initial$30,000,002No comparison10SEC filing
Jun 6, 2011Amendment$10,857,236$2,902,759vs Jan 25, 201113SEC filing
Jan 25, 2011Initial$7,954,477No comparison11SEC filing
Jul 1, 2010Initial$2,600,441No comparison12SEC filing
May 3, 2010Initial$200,011No comparison5SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-246857

Source: Form D, filed Sep 2, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Louis Cannon Director
Peter Cohn Executive
Michael Gertner Director, Executive
Brian Halak Director
Hank Plain Director
Henry A. Plain, Jr. Director
Christopher Shen Director
Immanuel Thangaraj Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2495 140 Th Ave N.E., Bldg D100
Bellevue, WA, 98005